Stocks and Investing
Stocks and Investing
Wed, April 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Suraj Kalia Maintained (ATRC) at Buy with Increased Target to $75 on, Apr 28th, 2021
Suraj Kalia of Oppenheimer, Maintained "AtriCure, Inc." (ATRC) at Buy with Increased Target from $65 to $75 on, Apr 28th, 2021.
Suraj has made no other calls on ATRC in the last 4 months.
There is 1 other peer that has a rating on ATRC. Out of the 1 peers that are also analyzing ATRC, 0 agree with Suraj's Rating of Hold.
This is the rating of the analyst that currently disagrees with Suraj
- Danielle Antalffy of "SVB Leerink" Maintained at Buy with Increased Target to $78 on, Wednesday, February 24th, 2021
Contributing Sources